1. Diego B. El gasto de la UE en medicamentos crecerá hasata el 7% en cinco años [Internet]. Diariofarma. [consultado 12 Ago 2018]. Disponible en: https://www.diariofarma.com/2016/01/11/el-gasto-de-la-ue-en-medicamentos-crecera-hasta-el-7-en-cinco-anos
2. Obstacles to the adoption of biosimilars for chronic diseases;Hakim;JAMA.,2017
3. Bisimilars approved in Europe [Internet]. GaBI Online Generics and Biosimilars Iniciative. [consultado 11 Ago 2018]. Disponible en: http://www.gabionline.net/Biosimilars/General/Biosimilars-approved-in-Europe
4. The biosimilarity concept: Toward an integrated framework for evidence assessment;Zineh;Ann Intern Med.,2016
5. Switching to biosimilar infliximab (CT-P13): Evidence of clinical safety, effectiveness and impact on public health;Braun;Biol J Int Assoc Biol Stand.,2016